See also this year's filing and all EDGAR filings for this company.
PDF Report 0001723128_2020_Amneal_Pharmaceuticals_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.0048439979651082295, 'aggregate_val': 3665890000, 'exp_sum': 3683734000, 'exp_to_value': {'AssetsCurrent': 1210210000, 'IntangibleAssetsNetIncludingGoodwill': 1802257000, 'PropertyPlantAndEquipmentNet': 477997000, 'remainder_Assets': 193270000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001723128, Amneal Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,210,210,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,802,257,000 |
| 2 | PropertyPlantAndEquipmentNet | 477,997,000 |
| 3 | remainder_Assets | 175,426,000 |
| 4 | LiabilitiesCurrent | 550,406,000 |
| 5 | LiabilitiesNoncurrent | 2,768,696,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 1,147,214,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 289,598,000 |
| 9 | ResearchAndDevelopmentExpense | 188,049,000 |
| 10 | remainder_Expenses | 621,083,000 |
| 11 | remainder_Revenues | 1,626,373,000 |
| 12 | remainder_NetIncome | 15,998,000 |
| 13 | remainder_ComprehensiveNetIncome | 250,151,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,665,890,000 |
| 1 | Liabilities | 3,319,102,000 |
| 2 | Expenses | 2,245,944,000 |
| 3 | Revenues | 1,626,373,000 |
| 4 | StockholdersEquity | 346,788,000 |
| 5 | NetIncome | -603,573,000 |
| 6 | ComprehensiveNetIncome | -478,497,500 |
| 7 | BaseVar | 5,561,729,000 |
| 8 | EconomicCapitalRatio | 0.0338 |
Edgar->Model Mapping
Feature Distribution
Change over Time
